CRVO

1.4609.77%
JJ

John J. Alam

Co-Founder, CEO, President & Director

Dr. John J. Alam, M.D. serves as Chief Executive Officer at CervoMed Inc. (Formerly, EIP Pharma, LLC) and also serves as its President since August 2023 and serves as its Director since August 2023. He is a Co-Founder of CervoMed Inc. (Formerly, EIP Pharma, LLC) since 2014. He has been a Senior Medical Advisor at Inhibitex, Inc. since April 2010. From January 2011 to August 2014, Dr. Alam served as Head of the Therapeutic Strategic Area for Diseases of Aging at sanofi-aventis. From 1997 to 2008, Dr. Alam held various positions of increasing responsibility at Vertex and was responsible for leading telaprevir from preclinical to Phase III development. Dr. Alam served as the Chief Medical Officer and Executive Vice President of Medicines Development at Vertex Pharmaceuticals Incorporated since February 2006. He served as Senior Vice President of Drug Evaluation and Approval at Vertex Pharmaceuticals Incorporated from January 2001 to February 2006. He served as Vice President of Clinical Development of Vertex Pharmaceuticals Incorporated from October 1997 to January 2001. He joined Vertex Pharmaceuticals Incorporated from Biogen, Inc. where he served from 1991 to 1997, including Director of Medical Research and Program Executive for Avonex (beta interferon). Prior to joining Biogen, he served as a Research Fellow at the Dana Farber Cancer Institute and had completed an internal medicine residency at The Brigham and Women's Hospital in Boston. He has been a Director of Pathfinder Cell Therapy, Inc. since September 2011. Dr. Alam is a Distinguished Fellow at the Center for Biomedical Innovation at the Massachusetts Institute of Technology (MIT). Dr. Alam holds an M.D. from Northwestern University Medical School and a S.B. in Chemical Engineering from the Massachusetts Institute of Technology.

Positions